
Biography
Adam Elliston is the Automation Specialist at the Earlham DNA Foundry. The Foundry provides the UK bioscience community access to automated platforms for nano-scale modular DNA assembly, verification and delivery to plant and microbial cells. It is also able to serve as a repository for large collections of DNA parts.
Adam is a biotechnologist with a background in liquid handling and automation. His PhD was in biotechnology and biorefining from the University of East Anglia, UK where his thesis was focussed on converting municipal solid waste in to biofuels and platform chemicals.
He continued this work in the Biorefinery Centre at the Quadram Institute, UK working on high throughput screening methodologies for yeast fermentation, DNA extraction and second-generation biofuel production.
Adam’s background in automation comes from his bachelor’s degree in Cybernetics and Control Engineering from the University of Reading, UK and he has over 10 years’ experience working in biotechnology both at laboratory and small industrial scale.
Publications
Related reading.

Finding fungi at the fen

The genetic machinery that drives biodiversity

On the origin of errors: the causes and consequences of mistakes during DNA replication

Could long-read RNA sequencing be the future of drug discovery?

Why is genome annotation important?

Why cloud computing is important for data-driven bioscience research

How bioinformatics can crack the complex case of protist biodiversity

The dramatic effects genomics will have on our future world

Exotic wheat DNA could help breed ‘climate-proof’ crops

Sequencing project to unleash the huge potential of euglenoids

Circadian clock insights could be key to increased wheat yields

European consortium launched to reverse biodiversity loss through genomics research

Tracking bacterial evolution in real time spots emergence of antimicrobial resistance

Big Data initiative awarded £6.3 million as part of major UKRI investment in research infrastructure

Not all looks rosy for the pink pigeon

Coronavirus jams communication signals to immune cells in the gut
